Form 8-K - Current report:
SEC Accession No. 0000950170-22-000624
Filing Date
2022-02-01
Accepted
2022-02-01 09:01:06
Documents
13
Period of Report
2022-02-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K allk-20220201.htm   iXBRL 8-K 52270
2 EX-99.1 allk-ex99_1.htm EX-99.1 15820
  Complete submission text file 0000950170-22-000624.txt   184858

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT allk-20220201_lab.xml EX-101.LAB 12890
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT allk-20220201.xsd EX-101.SCH 2492
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT allk-20220201_pre.xml EX-101.PRE 9543
7 EXTRACTED XBRL INSTANCE DOCUMENT allk-20220201_htm.xml XML 4514
Mailing Address 975 ISLAND DRIVE SUITE 201 REDWOOD CITY CA 94065
Business Address 975 ISLAND DRIVE SUITE 201 REDWOOD CITY CA 94065 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

EIN.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38582 | Film No.: 22577098
SIC: 2834 Pharmaceutical Preparations